Wockhardt LimitedNSE: WOCKPHARMA

Press Release Oct 16 2024

· Issued by Wockhardt Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-16-2024-4

Wockhardt Limited has informed the Exchange regarding a press release dated October 16, 2024, titled - Wockhardt files fast-acting Insulin Aspart injection (ASPARAPIDTM) with DCGI; strengthens commitment to diabetes management .

View Attachment

6ix hasn’t read this filing yet.

Wockhardt Limited on 6ix

Earlier from Wockhardt

Later from Wockhardt

All Wockhardt news releases